Paper40534883
Immune-mediated renal injury in diabetic kidney disease: from mechanisms to therapy.
Ma L and 4 others. Front Immunol, 2025. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Immune-mediated renal injury in diabetic kidney disease: from mechanisms to therapy. Papers, record 40534883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40534883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Nephropathies | Major topic |
| Kidney | Major topic |
| Humans | |
| Animals | |
| Immunity, Innate | |
| Renin-Angiotensin System | |
| Immunotherapy |
Source PubMed
References160
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29336982 | IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice. | Metabolism | 2018 | https://conductscience.org/library/papers/29336982 | PubMed |
| 2 | 31078708 | M2a and M2b macrophages predominate in kidney tissues and M2 subpopulations were associated with the severity of disease of IgAN patients. | Clin Immunol | 2019 | https://conductscience.org/library/papers/31078708 | PubMed |
| 3 | 39192822 | T-Cell Senescence in Human Metabolic Diseases. | Diabetes Metab J | 2024 | https://conductscience.org/library/papers/39192822 | PubMed |
| 4 | 39511548 | Inhibition of SGLT2 protects podocytes in diabetic kidney disease by rebalancing mitochondria-associated endoplasmic reticulum membranes. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39511548 | PubMed |
| 5 | 37845748 | A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37845748 | PubMed |
| 6 | 35852798 | Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity? | Allergy | 2022 | https://conductscience.org/library/papers/35852798 | PubMed |
| 7 | 33679687 | Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome. | Front Immunol | 2020 | https://conductscience.org/library/papers/33679687 | PubMed |
| 8 | 38947237 | The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38947237 | PubMed |
| 9 | 30017263 | Effect of redox status of peripheral blood on immune signature of circulating regulatory and cytotoxic T cells in streptozotocin induced rodent model of type I diabetes. | Immunobiology | 2018 | https://conductscience.org/library/papers/30017263 | PubMed |
| 10 | 17167242 | Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. | Am J Nephrol | 2006 | https://conductscience.org/library/papers/17167242 | PubMed |
| 11 | 39340004 | The Potential of Anti-Inflammatory DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39340004 | PubMed |
| 12 | 18809387 | Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases. | Biochem Biophys Res Commun | 2008 | https://conductscience.org/library/papers/18809387 | PubMed |
| 13 | 30466341 | XAV939, a Wnt/β-catenin pathway modulator, has inhibitory effects on LPS-induced inflammatory response. | Immunopharmacol Immunotoxicol | 2019 | https://conductscience.org/library/papers/30466341 | PubMed |
| 14 | 28033563 | The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. | Redox Biol | 2017 | https://conductscience.org/library/papers/28033563 | PubMed |
| 15 | 29778663 | GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms. | Biochim Biophys Acta Mol Basis Dis | 2018 | https://conductscience.org/library/papers/29778663 | PubMed |
| 16 | 29387732 | Metabolic Plasticity in Dendritic Cell Responses: Implications in Allergic Asthma. | J Immunol Res | 2017 | https://conductscience.org/library/papers/29387732 | PubMed |
| 17 | 37561596 | Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37561596 | PubMed |
| 18 | 36012508 | Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone-Translational Aspects and Clinical Perspectives across Multiple Organ Systems. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012508 | PubMed |
| 19 | 35834985 | Activation of renal CSE/H2S pathway by alpha-lipoic acid protects against histological and functional changes in the diabetic kidney. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35834985 | PubMed |
| 20 | 37589053 | Loss of endothelial glucocorticoid receptor accelerates organ fibrosis in db/db mice. | Am J Physiol Renal Physiol | 2023 | https://conductscience.org/library/papers/37589053 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42714219 | Clinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease. | Ann Med | 2026 | https://conductscience.org/library/papers/42714219 | PubMed |
| 42511736 | Urinary Extracellular Vesicle-Derived miRNAs as Regulators and Biomarkers in Diabetic Kidney Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511736 | PubMed |
| 42494200 | Association of Serum Bilirubin Levels With Histopathological Severity of Diabetic Nephropathy in Patients With Type 2 Diabetes: A Cross-Sectional Biopsy Study. | J Diabetes Res | 2026 | https://conductscience.org/library/papers/42494200 | PubMed |
| 42466352 | From pathogenic carriers to therapeutic hope: the dual role and translational prospects of exosomes in diabetic kidney disease. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42466352 | PubMed |
| 42420893 | Mechanisms by which macrophage Ltb4r1 mediates tubular epithelial cell injury to facilitate the advancement of diabetic kidney disease. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/42420893 | PubMed |
| 42416061 | cGAS-STING pathway in innate immunity and its cell-specific role in kidney diseases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42416061 | PubMed |
| 42371495 | Mechanistic Insights and Therapeutic Advances of Anti-Inflammatory Biologics in Immune-Mediated Glomerulonephritis: A Narrative Review. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42371495 | PubMed |
| 42254676 | Dapagliflozin attenuates diabetic renal fibrosis by inhibiting macrophage-myofibroblast transition via the TGF-β1-Smad3/7 pathway. | PeerJ | 2026 | https://conductscience.org/library/papers/42254676 | PubMed |
| 42220095 | Morphological and Biochemical Insights Into the Renoprotective Effects of Combined N-Acetylcysteine and Glycine Treatment in Experimental Diabetic Nephropathy. | Pharmacol Res Perspect | 2026 | https://conductscience.org/library/papers/42220095 | PubMed |
| 42196627 | Investigating the Effects and Potential Mechanisms of Astragalus Root Against Diabetic Nephropathy Based on Bioinformatics Analysis and In Vitro Validation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196627 | PubMed |
| 42195274 | Network Pharmacology and Molecular Docking-Based Investigation of Empagliflozin's Therapeutic Potential in Chronic Kidney Disease. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42195274 | PubMed |
| 42099640 | Molecular immunopharmacology of traditional Chinese medicine-derived compounds in membranous nephropathy: mechanistic insights into immune aging and kidney essence deficiency. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099640 | PubMed |
| 41909676 | Unveiling the immune microenvironment in diabetic nephropathy: from mechanisms to therapeutics. | Front Immunol | 2026 | https://conductscience.org/library/papers/41909676 | PubMed |
| 41907207 | SIRT2 in Diabetic Kidney Disease: Multifaceted Regulatory Roles and Therapeutic Challenges. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/41907207 | PubMed |
| 41878449 | Identification of PANoptosis hub genes driving immune activation and tubulointerstitial injury in diabetic kidney disease by integrative bioinformatics and machine learning. | Front Immunol | 2026 | https://conductscience.org/library/papers/41878449 | PubMed |
| 41858086 | Focusing on the Apolipoprotein M-Mitophagy Axis: A Mechanism for Renal Protection in Diabetic Nephropathy. | J Diabetes Res | 2026 | https://conductscience.org/library/papers/41858086 | PubMed |
| 41828379 | Connexin 43 and Pannexin 1 in Renal Cell Populations in Diabetic Kidney Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41828379 | PubMed |
| 41797844 | Molecular pathways and emerging therapeutic targets in the pathogenesis of diabetic kidney disease. | Front Physiol | 2026 | https://conductscience.org/library/papers/41797844 | PubMed |
| 41795784 | Isoprenaline alleviates diabetic kidney disease via multi-target inhibition of the cGAS-STING pathway. | Biosci Rep | 2026 | https://conductscience.org/library/papers/41795784 | PubMed |
| 41742267 | From the energy factory to the intercellular communication medium: the emerging role of intercellular mitochondrial transfer and mitochondrial transplantation therapy in diabetes and diabetic complications. | J Transl Med | 2026 | https://conductscience.org/library/papers/41742267 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40534883
GET https://conductscience.org/api/papers/v1/40534883/references?page=2